
13 · HUTCHMED (China) Limited
21.54
HKDUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
HK$19.02B
PE
5.10
EV/EBITDA
N/A
DIV Yield
0%
Payout Ratio
0%
MQV Rating
3Neutral
As at 18/09/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- All-Consensus
- Consensus Cheap
- EMA 125 Breakup
- HALO All
- HALO Earnings Momentum
- HALO Small
- Recent Earnings upgrade
- Recent Price upgrade
- Short Term Trend - Long
Key Fundamentals
EPS 3 yr Growth
-225.00%
EBITDA Margin
-5.90%
Operating Cashflow
-$65m
Free Cash Flow Return
-6.10%
ROIC
43.00%
Interest Coverage
-11.30
Quick Ratio
4.80
Performance
52 weeks range
Low 15.57 - 28.1
Trade Value (12mth)
US$3,368,694.00
1 week
3.61%
1 month
10.32%
YTD
4.11%
1 year
-13.08%
All time high
85.80
Additional Data
Shares Outstanding (Fully Diluted)
873m
HALO Sector
Healthcare
Next Company Report Date
04-Mar-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Very Strong
Event
Neutral
Halo Model
Mqv
Neutral
Garp
Very Weak
Mqv Small
Neutral
Momentum
Price
Strong
Earnings
Very Strong
Growth
Earnings
Weak
Dividends
Very Weak
Quality
Capital Efficiency
Weak
Balance Sheet
Neutral
Valuation
News & Announcements
No announcements available.
Key Stakeholders
| Name | Title |
| CK Hutchison Holdings Ltd. | Public Company |
| Wei Guo Su | Individual |
| Invesco Great Wall Fund Management Co. Ltd. | Joint Venture |
| Chig Fung Cheng | Individual |
| Edith Shih | Individual |